TNF and congenital rubella syndrome: These data show that anti-TNF-α pre-treatment can hamper or lessen most effects of OKT3-induced CRS in hFlt3L-boosted BRGSF-CBC mice, thus providing a relevant preclinical model for CRS-managing treatments’ assessment.